
Plausibility and Undue Burden: A New Look at Insufficiency after FibroGen v Akebia
FibroGen Inc. v Akebia Therapeutics Inc. and another company; Astellas Pharma Inc. v Akebia Therapeutics
December 2, 2021
Recent Articles
Some recent articles from our member community.

Patent Filing Litigations Continue to Increase Despite the COVID-19 Pandemic
Looking back at the past decade, in 2013, filings of
azami
February 2, 2022

Getting the Most from Medical-Use Claims in Australia
Australia stands apart from many other key jurisdictions in allowing
azami
December 2, 2021

Plausibility and Undue Burden: A New Look at Insufficiency after FibroGen v Akebia
FibroGen Inc. v Akebia Therapeutics Inc. and another company; Astellas
azami
December 2, 2021
Get our insights delivered straight to your inbox.
